Drug Markets/Tipranavir

Tipranavir

1 NDC across 1 manufacturer|0 Generic,1 Brand

Tipranavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jun 22, 2005. In 2024, Medicare Part D spent $1 million on Tipranavir across 500 claims for 56 beneficiaries.

Tipranavir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $16.79 to $16.79 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$16.79 – $16.79

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing TIPRANAVIR

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
APTIVUS 250 MG CAPSULE
$16.7859
per EA
—

Frequently Asked Questions

What is Tipranavir used to treat?

Tipranavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Tipranavir?

In 2024, Medicare Part D spent $1 million on Tipranavir across 500 claims for 56 beneficiaries.

How many Tipranavir products are on the market?

The Tipranavir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Tipranavir?

NADAC reference prices for Tipranavir range from $16.7859 to $16.7859 per EA.

Which manufacturers make Tipranavir?

1 manufacturer lists Tipranavir in NADAC. Ranked by number of NDCs, the largest are Boehringer Ingelheim Pharmaceuticals Inc. (1).